How much is Siolta Therapeutics worth in 2026?

Siolta Therapeutics has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has Siolta Therapeutics raised?

Siolta Therapeutics has raised N/A in total funding across 2 funding rounds.

Siolta Therapeutics

Drug Discovery

Siolta Therapeutics valuation and funding history | Last updated: March 12, 2024 | 2 funding rounds

Current Valuation

N/A

As of March 12, 2024

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series C)

$12.0M

Last Funding

Mar 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 12, 2024	Later Stage VC (Series C)	$12.0M	N/A	-
April 10, 2018	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Siolta Therapeutics is currently valued at N/A as of March 12, 2024.

Track Siolta Therapeutics Valuation Updates

Get notified when Siolta Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Siolta Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Siolta Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Siolta Therapeutics Worth in 2026?

Siolta Therapeutics is a leading private company in the Drug Discovery sector. Track Siolta Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Siolta Therapeutics Valuation is Determined

Private company valuations like Siolta Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.